Anti-SLC25A13抗体
产品名称： Anti-SLC25A13抗体
英文名称： SLC25A13
产品编号： YB--4038R
产品价格： null
产品产地： 中国/美国
品牌商标： Ybscience
更新时间： 2023-08-17T10:29:50
使用范围： 科研使用
上海钰博生物科技有限公司
- 联系人 : 陈环环
- 地址 : 上海市沪闵路6088号龙之梦大厦8楼806室
- 邮编 : 200612
- 所在区域 : 上海
- 电话 : 183****2235 点击查看
- 传真 : 点击查看
- 邮箱 : shybio@126.com
- 二维码 : 点击查看
Anti-SLC25A13抗体
| 产品编号 | YB-4038R |
| 英文名称 | SLC25A13 |
| 中文名称 | 线粒体内钙结合天冬氨酸/谷氨酸载体蛋白抗体 |
| 别 名 | ARALAR2; Calcium binding mitochondrial carrier protein Aralar2; Citrin; CTLN2; Ctrn; Mitochondrial aspartate glutamate carrier 2; RGD1565889; Solute carrier family 25 (citrin) member 13; Solute carrier family 25 member 13 (citrin); Solute carrier family 25 member 13; AI785475; CMC2_HUMAN. |
| 规格价格 | 100ul/1380元 购买 200ul/2200元 购买 大包装/询价 |
| 说 明 书 | 100ul 200ul |
| 研究领域 | 肿瘤 细胞生物 免疫学 神经生物学 结合蛋白 线粒体 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 交叉反应 | Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, |
| 产品应用 | WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 IF=1:100-500 （石蜡切片需做抗原修复） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 74kDa |
| 细胞定位 | 细胞浆 细胞膜 线粒体 |
| 性 状 | Lyophilized or Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human SLC25A13:351-450/675 |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 储 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存条件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| PubMed | PubMed |
| 产品介绍 | background: SLC25A13 is a member of the mitochondrial carrier family. It contains four EF-hand Ca(2+) binding motifs in the N-terminal domain, and localizes to mitochondria. It catalyzes the exchange of aspartate for glutamate and a proton across the inner mitochondrial membrane, and is stimulated by calcium on the external side of the inner mitochondrial membrane. Mutations in the SLC25A13 gene result in citrullinemia, type II. Multiple transcript variants encoding different isoforms have been found for this gene. Function: Catalyzes the calcium-dependent exchange of cytoplasmic glutamate with mitochondrial aspartate across the mitochondrial inner membrane. May have a function in the urea cycle. Subcellular Location: Mitochondrion inner membrane; Multi-pass membrane protein. Tissue Specificity: High levels in liver and low levels in kidney, pancreas, placenta, heart and brain. DISEASE: Defects in SLC25A13 are the cause of citrullinemia type 2 (CTLN2) [MIM:603471]. Citrullinemia belongs to the urea cycle disorders. It is an autosomal recessive disease characterized primarily by elevated serum and urine citrulline levels. Ammonia intoxication is another manifestation. CTLN2 is characterized by neuropsychiatric symptoms including abnormal behaviors, loss of memory, seizures and coma. Death can result from brain edema. Onset is sudden and usually between the ages of 20 and 50 years. Defects in SLC25A13 are the cause of neonatal intrahepatic cholestasis due to citrin deficiency (NICCD) [MIM:605814]. NICCD is a form of citrullinemia type 2 with neonatal onset. NICCD is characterized by suppression of the bile flow, hepatic fibrosis, low birth weight, growth retardation, hypoproteinemia, variable liver dysfunction. NICCD is generally not severe and symptoms disappear by one year of age with an appropriate diet. Years or even decades later, however, some individuals develop the characteristic features of citrullinemia type 2 with neuropsychiatric symptoms. Similarity: Belongs to the mitochondrial carrier family. Contains 4 EF-hand domains. Contains 3 Solcar repeats. SWISS: Q9UJS0 Gene ID: 10165 Database links: Entrez Gene: 10165 Human Entrez Gene: 50799 Mouse Entrez Gene: 362322 Rat Omim: 603859 Human SwissProt: Q9UJS0 Human SwissProt: Q9QXX4 Mouse Unigene: 489190 Human Unigene: 24513 Mouse Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. Citrin是一种线粒体内钙结合天冬氨酸/谷氨酸载体(Aspartate/ Glutamate Carrier, AGC)蛋白，在尿素循环及其他代谢过程中发挥重要作用。Citrin缺乏症包含成年发作Ⅱ型 瓜氨酸血症(Adult Onset Type Ⅱ Citrullinemia , CTLN2)和Citrin缺乏所致新生儿肝内胆汁淤积症( Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency, NICCD)两种不同表型，为常染色体隐性遗传。 Citrin分子量约为74kDa，含675个氨基酸，在肝脏、肾脏及心脏中均有表达，位于线粒体内膜。Citrin的N端有4个EF手型结构域，可结合钙离子，C端作为线粒体载体活性部位有6个跨膜结构。研究还发现，Citrin的类似物－Aralar，同为天冬氨酸/谷氨酸载体蛋白，虽氨基酸序列与Citrin有77.8%的同源性，但组织分布明显不同，Citrin主要在肝脏而Aralar 主要在骨骼肌和脑中表达，提示Citrin缺乏症是一种局限于肝脏的疾病。 Citrin作为肝内主要的天冬氨酸/谷氨酸载体蛋白，其功能有3方面； 其一，将线粒体中天冬氨酸转运至胞浆中，参与尿素、蛋白和核酸的合成。 其二，将天冬氨酸转运至胞浆，作为苹果酸/天冬氨酸穿梭的一个环节，将胞浆中糖酵解生成的NADH还原当量运至线粒体内，参与能量、氨基酸、糖和脂代谢。 其三，在NADH形成及利用的同时促进乳糖糖异生。 CTLN2患者多死于脑水肿，脑损伤机制尚不明确，高血氨并非唯一致病因素，局部缺血、能量耗竭、神经毒性及代谢失调引起氧化应激反应，均可加速脑损伤。CTLN2患者多并发肝脏肿瘤，其中大部分为肝细胞癌 。体外研究提示瓜氨酸的积聚对肝细胞的增生有促进作用，游离脂肪酸聚集造成的氧化应激和脂质过氧化反应对肿瘤发生也有重要作用 |